Genomate Health launches AI-powered cancer treatment service to close precision oncology gap

June 11, 2026

Genomate Health's Second Opinion Service combines physician oversight with computational reasoning technology to systematically analyze genomic findings, pathway interactions, treatment opportunities, and relevant clinical evidence. Every case undergoes multidisciplinary expert review, with findings and treatment considerations shared in a one-on-one telehealth consultation with a board-certified oncologist.

Other Media Coverage

See all

Other Resources